↓ Skip to main content

Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo

Overview of attention for article published in Molecular Cancer Therapeutics, March 2008
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
Published in
Molecular Cancer Therapeutics, March 2008
DOI 10.1158/1535-7163.mct-07-2037
Pubmed ID
Authors

Danijela Maksimovic-Ivanic, Sanja Mijatovic, Ljubica Harhaji, Djordje Miljkovic, Darrin Dabideen, Kai Fan Cheng, Katia Mangano, Graziella Malaponte, Yousef Al-Abed, Massimo Libra, Gianni Garotta, Ferdinando Nicoletti, Stanislava Stosic-Grujicic

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Uruguay 1 3%
Brazil 1 3%
Unknown 29 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 26%
Student > Ph. D. Student 7 23%
Researcher 6 19%
Student > Doctoral Student 2 6%
Librarian 1 3%
Other 4 13%
Unknown 3 10%
Readers by discipline Count As %
Chemistry 13 42%
Immunology and Microbiology 4 13%
Agricultural and Biological Sciences 3 10%
Medicine and Dentistry 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Other 3 10%
Unknown 3 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2018.
All research outputs
#7,577,096
of 23,106,934 outputs
Outputs from Molecular Cancer Therapeutics
#1,687
of 3,880 outputs
Outputs of similar age
#33,330
of 94,113 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#21
of 47 outputs
Altmetric has tracked 23,106,934 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,880 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,113 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.